A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: BIOLOGICAL: Ad-RTS-hIL-12|DRUG: Veledimex
Sponsor: Alaunos Therapeutics